BrightSpring Health Services, Inc. Common Stock (BTSG) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $53.16 (+10.89%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 18, 2026 | Whit Mayo | Leerink Partners | $49.00 | -7.8% |
| Feb 2, 2026 | David Larsen | BTIG | $55.00 | +3.5% |
| Jan 9, 2026 | Ann Hynes | Mizuho Securities | $45.00 | -15.4% |
| Dec 12, 2025 | Matthew Gillmor | KeyBanc | $45.00 | -15.4% |
| Nov 12, 2025 | Stephen Baxter | Wells Fargo | $39.00 | -26.6% |
| Oct 29, 2025 | Ann Hynes | Mizuho Securities | $38.00 | -28.5% |
| Oct 29, 2025 | David Larsen | BTIG | $41.00 | -22.9% |
| Oct 21, 2025 | Brian Tanquilut | Jefferies | $36.00 | -32.3% |
| Oct 7, 2025 | Stephen Baxter | Wells Fargo | $33.00 | -37.9% |
| Sep 8, 2025 | Pito Chickering | Deutsche Bank | $30.00 | -43.6% |
| May 5, 2025 | Ann Hynes | Mizuho Securities | $26.00 | -51.1% |
Top Analysts Covering BTSG
BTSG vs Sector & Market
| Metric | BTSG | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 14 | 8 | 18 |
| Target Upside | -8.3% | +1150.3% | +14.9% |
| P/E Ratio | 61.11 | 6.81 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $14.75B | $14.85B | $15.02B | 12 |
| 2027-03-31 | $3.73B | $3.81B | $3.88B | 4 |
| 2027-06-30 | $4.00B | $4.09B | $4.17B | 4 |
| 2027-09-30 | $4.20B | $4.29B | $4.38B | 5 |
| 2027-12-31 | $4.42B | $4.52B | $4.61B | 4 |
| 2028-03-31 | $4.27B | $4.36B | $4.45B | 3 |
| 2028-06-30 | $4.57B | $4.66B | $4.75B | 3 |
| 2028-09-30 | $4.85B | $4.96B | $5.06B | 5 |
| 2028-12-31 | $5.18B | $5.29B | $5.39B | 3 |
| 2029-12-31 | $21.92B | $23.05B | $23.67B | 5 |
| 2030-12-31 | $26.65B | $28.03B | $28.78B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.17 | $1.56 | $2.26 | 10 |
| 2027-03-31 | $0.39 | $0.40 | $0.41 | 3 |
| 2027-06-30 | $0.44 | $0.45 | $0.46 | 3 |
| 2027-09-30 | $0.50 | $0.51 | $0.53 | 4 |
| 2027-12-31 | $0.57 | $0.59 | $0.60 | 3 |
| 2028-03-31 | $0.56 | $0.58 | $0.60 | 4 |
| 2028-06-30 | $0.64 | $0.66 | $0.67 | 4 |
| 2028-09-30 | $0.75 | $0.77 | $0.79 | 6 |
| 2028-12-31 | $0.84 | $0.86 | $0.89 | 4 |
| 2029-12-31 | $3.38 | $3.62 | $3.74 | 2 |
| 2030-12-31 | $4.93 | $5.27 | $5.45 | 2 |
Frequently Asked Questions
What is the analyst consensus for BTSG?
The consensus among 14 analysts covering BrightSpring Health Services, Inc. Common Stock (BTSG) is Buy with an average price target of $44.18.
What is the highest price target for BTSG?
The highest price target for BTSG is $55.00, set by David Larsen at BTIG on 2026-02-02.
What is the lowest price target for BTSG?
The lowest price target for BTSG is $26.00, set by Ann Hynes at Mizuho Securities on 2025-05-05.
How many analysts cover BTSG?
14 analysts have issued ratings for BrightSpring Health Services, Inc. Common Stock in the past 12 months.
Is BTSG a buy or sell right now?
Based on 14 analyst ratings, BTSG has a consensus rating of Buy (2.00/5) with a -8.3% upside to the consensus target of $44.18.
What are the earnings estimates for BTSG?
Analysts estimate BTSG will report EPS of $1.56 for the period ending 2026-12-31, with revenue estimated at $14.85B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.